Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-05-17 pm EDT 5-day change 1st Jan Change
154.2 USD -0.02% Intraday chart for Agilent Technologies, Inc. +2.98% +10.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Agilent Technologies Says Padraig McDonnell Assumes CEO Role MT
Agilent Technologies Appoints Padraig McDonnell CEO MT
Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution CI
Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024 CI
Bernstein Adjusts Agilent Technologies' Price Target to $130 From $127 MT
Bernstein Adjusts Price Target on Agilent Technologies to $130 From $127 MT
Baird Adjusts Price Target on Agilent Technologies to $147 From $143, Outperform Rating Kept MT
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed RE
Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic MT
Transcenta Holding Limited Announces Collaboration with Agilent Technologies to Develop a Claudin18.2 Companion Diagnostic to Support TranStar301 Global Phase III Trial CI
Have investors resigned themselves to fewer rate cuts? Our Logo
Stifel Upgrades Agilent Technologies to Buy From Hold, Raises Price Target to $163 From $145 MT
ANALYST RECOMMENDATIONS : Agilent Technologies, Eaton Corporation, Citigroup, Royal Bank of Canada, Newmont Corporation.... Our Logo
Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics CI
Biofidelity Ltd. announced that it has received $24 million in funding from Agilent Technologies, Inc., Octopus Ventures Ltd., Blue Yard Capital, Longwall Venture Partners LLP CI
Agilent Technologies Inc. and University of California San Diego Launch Center of Excellence in Cellular Intelligence CI
Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency CI
Agilent Technologies Insider Sold Shares Worth $417,096, According to a Recent SEC Filing MT
Masimo Activist Investor Politan Capital Nominates 2 Board Candidates MT
Masimo Activist Investor Politan Capital Nominates 2 Board Candidates MT
Activist investor Politan plans second proxy battle at Masimo, WSJ reports RE
Declaration of Voting Results by Agilent Technologies CI
Transcript : Agilent Technologies, Inc. - Shareholder/Analyst Call
Agilent Technologies Insider Sold Shares Worth $7,844,550, According to a Recent SEC Filing MT
Exclusive-Icahn drops Illumina board challenge threat, sources say RE
Chart Agilent Technologies, Inc.
More charts
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (73.9%) and services (26.1%). Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
154.2 USD
Average target price
150.9 USD
Spread / Average Target
-2.13%
Consensus
  1. Stock Market
  2. Equities
  3. A Stock
  4. News Agilent Technologies, Inc.
  5. Masimo Activist Investor Politan Capital Nominates 2 Board Candidates
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW